Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Sorting nexin-10 (SNX10) is a member of the phox homology (PX) domain-containing family of phosphoinositide-binding proteins localized to endosomes, where it regulates intracellular trafficking, endosome organization, and protein localization to centrosomes and cilia. SNX10 is highly expressed in bone and gut, with important roles in bone mineral and calcium homeostasis through the regulation of osteoclastic bone resorption and gastric acid secretion. Pathogenic mutations in SNX10 are linked to autosomal recessive osteopetrosis (ARO), leading to increased bone density, bone marrow failure, and anemia. Beyond the skeleton, SNX10 has emerging roles in cancer, metabolic diseases, inflammation, and autophagy. The structure of SNX10 reveals it contains an extended PX domain distinctive from related family members, and its dysfunction has broad implications for human disease and cellular trafficking[1][2][3][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sorting nexin-10 (SNX10).